Subsequent studies have underscored the crucial role of MACC1 expression in cisplatin resistance in tongue squamous cell, ovarian and lung cancer through the activation of PI3K/AKT and ERK 1/2 signaling pathways [42, 104, 178]. This evidence concerns the gene MACC1 and lung carcinoma.